Biology Reference
In-Depth Information
Recombinant human erythropoietin improves health-related quality of life in patients with
rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with dis-
ease activity measures.
Rheumatol Int
18: 201-206
86 Ballard H, Rana J, Ackerman A, Merino R, Rosenoff S, Kastritsis C, Trout R, Chaudhaury M,
Auerbach M (1999) Total dose infusion (TDI) of iron dextran (ID) optimizes erythropoietin (EPO)
responsiveness in the anemia of cancer (CA).
Proc Am Soc Clin Oncol
18: A2245
87 Kuhns WJ, Gubler CJ, Cartwright GE, Wintrobe MM (1950) The anemia of infection. XIV.
Response to massive doses of intravenously administered saccharated oxide of iron.
J Clin Invest
29: 1505-1513
88 Bentley DP, Williams P (1982) Parenteral iron therapy in the anemia of rheumatoid arthritis.
Rheumatol Rehab
21: 88-92
89 Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H (1988) Clinical use of the total
dose intravenous infusion of iron dextran.
J Lab Clin Med
111: 566-570
90 Thompson FL, Powers JS, Graber SE, Krantz SB (1991) Use of recombinant human erythropoi-
etin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and
the anemia of chronic disease.
Am J Med
90: 398-400
91 Goodnough LT, Marcus RE (1997) The erythropoietic response to erythropoietin in patients with
rheumatoid arthritis.
J Lab Clin Med
130: 381-386
92 Goodnough LT, R u dnik S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall
MS, Lenes BA, Menitove JE et al. (1989) Increased preoperative collection of autologous blood
with recombinant human erythropoietin therapy.
N Engl J Med
321: 1163-1168
93 Coccia MA, Cooke K, Stoney G, Pistillo J, Del Castillo J, Duryea D, Tarpley GA, Molineux G
(2001) Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated
with chronic inflammatory disease in a rodent model.
Exp Hematol
10: 1201-1209
94Smith RE, Jaiyesima IA, Meza LA, Tchekmediyan NS, Chan D, Griffith H, Brosman S, Bukowski
R, Murdoch M, Rarick M et al. (2001) Novel erythropoieisis stimulating protein (NESP) for the
treatment of the anemia of chronic disease associated with cancer.
Br J Cancer
84: 24-30
